Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Tousseyn

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Journal of Clinical Immunology|October 13, 2018
Chronic Aichi Virus Infection in a Patient with X-Linked AgammaglobulinemiaGiorgia Bucciol, Leen Moens, Kathryn Payne, et al.
Plos One|July 25, 2014
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphomaJulio Finalet Ferreiro, Leila Rouhigharabaei, Helena Urbankova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2025
Optical Genome Mapping Is a Powerful Diagnostic Tool in Non-Hodgkin LymphomaAmber Verhasselt, Geneviève Ameye, Justine Vanhevel, et al.
Genes, Chromosomes & Cancer|February 7, 2016
Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignanciesKatrien Van Roosbroeck, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
Leukemia|July 16, 2025
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingTobias Rausch, Hendrik Schäfer, Julia Bein, et al.
British Journal of Cancer|November 25, 2016
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switchingLinde De Smedt, Sofie Palmans, Daan Andel, et al.
Cancer Immunology, Immunotherapy : CII|February 17, 2021
Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Nature Communications|June 18, 2021
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specifiedKoen Debackere, Lukas Marcelis, Sofie Demeyer, et al.
Leukemia & Lymphoma|February 28, 2013
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factorsDaan Dierickx, Thomas Tousseyn, Xavier Sagaert, et al.
Blood|August 12, 2022
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphomaMarlies Vanden Bempt, Koen Debackere, Sofie Demeyer, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Journal of Clinical Immunology|October 13, 2018
Chronic Aichi Virus Infection in a Patient with X-Linked AgammaglobulinemiaGiorgia Bucciol, Leen Moens, Kathryn Payne, et al.
Plos One|July 25, 2014
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphomaJulio Finalet Ferreiro, Leila Rouhigharabaei, Helena Urbankova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2025
Optical Genome Mapping Is a Powerful Diagnostic Tool in Non-Hodgkin LymphomaAmber Verhasselt, Geneviève Ameye, Justine Vanhevel, et al.
Genes, Chromosomes & Cancer|February 7, 2016
Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignanciesKatrien Van Roosbroeck, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
Leukemia|July 16, 2025
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingTobias Rausch, Hendrik Schäfer, Julia Bein, et al.
British Journal of Cancer|November 25, 2016
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switchingLinde De Smedt, Sofie Palmans, Daan Andel, et al.
Cancer Immunology, Immunotherapy : CII|February 17, 2021
Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Nature Communications|June 18, 2021
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specifiedKoen Debackere, Lukas Marcelis, Sofie Demeyer, et al.
Leukemia & Lymphoma|February 28, 2013
Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factorsDaan Dierickx, Thomas Tousseyn, Xavier Sagaert, et al.
Blood|August 12, 2022
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphomaMarlies Vanden Bempt, Koen Debackere, Sofie Demeyer, et al.
Pageof 18